Both in Pharmaceuticals
Fortress Biotech vs Spero Therapeutics
Over the past year FBIO returned −23.4% and SPRO returned −50.8%; their daily moves had a correlation of -0.00.
FBIO −23.4% SPRO −50.8%Growth of $1, one year, split-adjusted
| Metric | FBIO | SPRO |
|---|---|---|
| Price | $1.96 | $1.17 |
| Market cap | $65.4M | $68.1M |
| Today | +1.55% | +2.63% |
| 1 month | −10.9% | −2.5% |
| 6 months | −11.7% | −53.8% |
| Year to date | −46.4% | −49.8% |
| 1 year | −23.7% | −48.9% |
| Revenue growth (YoY) | +14.0% | −100.0% |
| Gross margin | 67.2% | — |
| Net margin | −13.2% | — |
| P/E (TTM) | 0.6× | 9.2× |
| Price / sales | 0.9× | 1.4× |
| Net cash | $157.0M | $50.7M |
| Dividend yield | — | — |
| Volatility (60d) | 45.0% | 57.4% |
| Short % of float | 17.7% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).